<DOC>
	<DOCNO>NCT01601665</DOCNO>
	<brief_summary>The purpose study evaluate use toric high cylinder power intraocular lens large population clinical practice assure continue safety approve device .</brief_summary>
	<brief_title>Post Approval Study AcrySof® IQ Toric Intraocular Lens ( IOL ) Models SN6AT6-SN6AT9</brief_title>
	<detailed_description>In prospective , non-randomized , unmasked study , subject pre-existing corneal astigmatism ≥2.57 diopter choose implant either AcrySof® IQ Toric High Cylinder Power IOL AcrySof® IQ Aspheric NATURAL monofocal IOL .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Diagnosed bilateral cataract target astigmatism range . Planned cataract removal phacoemulsification . Pupil size great equal 6 mm dilation . Able undergo second eye surgery within 30 day first eye surgery . Other protocoldefined inclusion criterion may apply . Irregular corneal astigmatism . Any inflammation swell cornea . Any corneal abnormality regular corneal astigmatism . Previous corneal refractive surgery . Amblyopia . Diabetic retinopathy . Uncontrolled glaucoma . Currently participate another investigational drug device study may confound result investigation . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Intraocular lens</keyword>
	<keyword>Cataracts</keyword>
	<keyword>Astigmatism</keyword>
	<keyword>Toric</keyword>
</DOC>